Enhanced Recruitment of CX3CR1+ T Cells by Mucosal Endothelial Cell-Derived Fractalkine in Inflammatory Bowel Disease

Gastroenterology

Volumn 132, Issue 1, 2007, Pages 139-153

  Sans, Miquel ^a,b   Danese, Silvio ^c   de la Motte, Carol ^d   de Souza, Heitor S P ^d   Rivera Reyes, Brenda M ^a   West, Gail A ^d   Phillips, Manijeh ^d   Katz, Jeffry A ^a   Fiocchi, Claudio ^d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTEGRIN; CX3C CHEMOKINE; FRACTALKINE; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LEUKOCYTE; LEUKOCYTE MIGRATION; MICROVASCULATURE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 33846216007     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.10.010     Document Type: Article

References (66)

1. Cook-Mills J.M., and Deem T.L. Active participation of endothelial cells in inflammation. J Leukoc Biol 77 (2005) 487-495
2. Muller W.A. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24 (2003) 327-334
3. Panés J., and Granger D.N. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114 (1998) 1066-1090
4. Proudfoot A.E., Power C.A., Rommel C., and Wells T.N. Strategies for chemokine antagonists as therapeutics. Semin Immunol 15 (2003) 57-65
5. van Buul J.D., and Hordijk P.L. Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 24 (2004) 824-833
6. Papadakis K.A. Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep 4 (2004) 83-89
7. Umehara H., Bloom E., Okazaki T., Domae N., and Imai T. Fractalkine and vascular injury. Trends Immunol 22 (2001) 602-607
8. Haskell C.A., Cleary M.D., and Charo I.F. Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion. J Biol Chem 275 (2000) 34183-34189
9. Fong A.M., Erickson H.P., Zachariah J.P., Poon S., Schamberg N.J., Imai T., and Patel D.D. Ultrastructure and function of the fractalkine mucin domain in CX(3)C chemokine domain presentation. J Biol Chem 275 (2000) 3781-3786
10. Hundhausen C., Misztela D., Berkhout T.A., Broadway N., Saftig P., Reiss K., Hartmann D., Fahrenholz F., Postina R., Matthews V., Kallen K.J., Rose-John S., and Ludwig A. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102 (2003) 1186-1195
11. Tsou C.L., Haskell C.A., and Charo I.F. Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 276 (2001) 44622-44626
12. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., and Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 385 (1997) 640-644
13. Umehara H., Bloom E.T., Okazaki T., Nagano Y., Yoshie O., and Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24 (2004) 34-40
14. Hatori K., Nagai A., Heisel R., Ryu J.K., and Kim S.U. Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69 (2002) 418-426
15. Cockwell P., Chakravorty S.J., Girdlestone J., and Savage C.O. Fractalkine expression in human renal inflammation. J Pathol 196 (2002) 85-90
16. Muehlhoefer A., Saubermann L.J., Gu X., Luedtke-Heckenkamp K., Xavier R., Blumberg R.S., Podolsky D.K., MacDermott R.P., and Reinecker H.C. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol 164 (2000) 3368-3376
17. Imaizumi T., Yoshida H., and Satoh K. Regulation of CX3CL1/fractalkine expression in endothelial cells. J Atheroscler Thromb 11 (2004) 15-21
18. Fraticelli P., Sironi M., Bianchi G., D'Ambrosio D., Albanesi C., Stoppacciaro A., Chieppa M., Allavena P., Ruco L., Girolomoni G., Sinigaglia F., Vecchi A., and Mantovani A. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107 (2001) 1173-1181
19. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., and Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 (1997) 521-530
20. Combadiere C., Salzwedel K., Smith E.D., Tiffany H.L., Berger E.A., and Murphy P.M. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J Biol Chem 273 (1998) 23799-23804
21. Haskell C.A., Cleary M.D., and Charo I.F. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem 274 (1999) 10053-10058
22. Greaves D.R., Hakkinen T., Lucas A.D., Liddiard K., Jones E., Quinn C.M., Senaratne J., Green F.R., Tyson K., Boyle J., Shanahan C., Weissberg P.L., Gordon S., and Yla-Hertualla S. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21 (2001) 923-929
23. Furuichi K., Wada T., Iwata Y., Sakai N., Yoshimoto K., Shimizu M., Kobayashi K., Takasawa K., Kida H., Takeda S., Matsushima K., and Yokoyama H. Upregulation of fractalkine in human crescentic glomerulonephritis. Nephron 87 (2001) 314-320
24. Robinson L.A., Nataraj C., Thomas D.W., Howell D.N., Griffiths R., Bautch V., Patel D.D., Feng L., and Coffman T.M. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165 (2000) 6067-6072
25. Raychaudhuri S.P., Jiang W.Y., and Farber E.M. Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol 144 (2001) 1105-1113
26. Nanki T., Imai T., Nagasaka K., Urasaki Y., Nonomura Y., Taniguchi K., Hayashida K., Hasegawa J., Yoshie O., and Miyasaka N. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum 46 (2002) 2878-2883
27. Hasegawa M., Sato S., Echigo T., Hamaguchi Y., Yasui M., and Takehara K. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann Rheum Dis 64 (2005) 21-28
28. Isse K., Harada K., Zen Y., Kamihira T., Shimoda S., Harada M., and Nakanuma Y. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 41 (2005) 506-516
29. Brand S., Sakaguchi T., Gu X., Colgan S.P., and Reinecker H.C. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122 (2002) 166-177
30. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., Littman D.R., and Reinecker H.C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
31. Lederman S., Yellin M.J., Krichevsky A., Belko J., Lee J.J., and Chess L. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med 175 (1992) 1091-1101
32. Binion D.G., West G.A., Ina K., Ziats N.P., Emancipator S.N., and Fiocchi C. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 112 (1997) 1895-1907
33. Harvey R.F., and Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet 1 (1980) 514
34. Sutherland L.R., Martin F., Greer S., Robinson M., Greenberger N., Saibil F., Martin T., Sparr J., Prokipchuk E., and Borgen L. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92 (1987) 1894-1898
35. Sturm A., Itoh J., Jacobberger J.W., and Fiocchi C. p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling. J Clin Invest 109 (2002) 1481-1492
36. Danese S., de la Motte C., Sturm A., Vogel J.D., West G.A., Strong S.A., Katz J.A., and Fiocchi C. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124 (2003) 1249-1264
37. Ropert C., Almeida I.C., Closel M., Travassos L.R., Ferguson M.A., Cohen P., and Gazzinelli R.T. Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J Immunol 166 (2001) 3423-3431
38. Thodeti C.K., Albrechtsen R., Grauslund M., Asmar M., Larsson C., Takada Y., Mercurio A.M., Couchman J.R., and Wewer U.M. ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem 278 (2003) 9576-9584
39. Feigelson S.W., Grabovsky V., Winter E., Chen L.L., Pepinsky R.B., Yednock T., Yablonski D., Lobb R., and Alon R. The Src kinase p56(lck) up-regulates VLA-4 integrin affinity. Implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin. J Biol Chem 276 (2001) 13891-13901
40. Musso A., Condon T.P., West G.A., De La M.C., Strong S.A., Levine A.D., Bennett C.F., and Fiocchi C. Regulation of ICAM-1-mediated fibroblast-T cell reciprocal interaction: implications for modulation of gut inflammation. Gastroenterology 117 (1999) 546-556
41. Vogel J.D., West G.A., Danese S., De La M.C., Phillips M.H., Strong S.A., Willis J., and Fiocchi C. CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology 126 (2004) 63-80
42. Roth S.J., Carr M.W., Rose S.S., and Springer T.A. Characterization of transendothelial chemotaxis of T lymphocytes. J Immunol Methods 188 (1995) 97-116
43. Umehara H., Goda S., Imai T., Nagano Y., Minami Y., Tanaka Y., Okazaki T., Bloom E.T., and Domae N. Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol Cell Biol 79 (2001) 298-302
44. Chapman G.A., Moores K.E., Gohil J., Berkhout T.A., Patel L., Green P., Macphee C.H., and Stewart B.R. The role of fractalkine in the recruitment of monocytes to the endothelium. Eur J Pharmacol 392 (2000) 189-195
45. Papadakis K.A., and Targan S.R. The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm Bowel Dis 6 (2000) 303-313
46. Fong A.M., Robinson L.A., Steeber D.A., Tedder T.F., Yoshie O., Imai T., and Patel D.D. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188 (1998) 1413-1419
47. Constantin G., Majeed M., Giagulli C., Piccio L., Kim J.Y., Butcher E.C., and Laudanna C. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13 (2000) 759-769
48. Chan J.R., Hyduk S.J., and Cybulsky M.I. Detecting rapid and transient upregulation of leukocyte integrin affinity induced by chemokines and chemoattractants. J Immunol Methods 273 (2003) 43-52
49. Mould A.P., Askari J.A., Barton S., Kline A.D., McEwan P.A., Craig S.E., and Humphries M.J. Integrin activation involves a conformational change in the alpha 1 helix of the beta subunit A-domain. J Biol Chem 277 (2002) 19800-19805
50. Lucas A.D., Chadwick N., Warren B.F., Jewell D.P., Gordon S., Powrie F., and Greaves D.R. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 158 (2001) 855-866
51. Podolsky D.K., and Fiocchi C. Cytokines, chemokines, growth factors, eicosanoids and other bioactive molecules in IBD. In: Kirsner J.B. (Ed). Inflammatory bowel disease (1999), W.B. Saunders, Philadelphia 191-207
52. Bolovan-Fritts C.A., Trout R.N., and Spector S.A. Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells. J Virol 78 (2004) 13173-13181
53. Hommes D.W., Peppelenbosch M.P., and van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52 (2003) 144-151
54. Hollenbach E., Neumann M., Vieth M., Roessner A., Malfertheiner P., and Naumann M. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J 18 (2004) 1550-1552
55. Hollenbach E., Vieth M., Roessner A., Neumann M., Malfertheiner P., and Naumann M. Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem 280 (2005) 14981-14988
56. Foussat A., Coulomb-L'Hermine A., Gosling J., Krzysiek R., Durand-Gasselin I., Schall T., Balian A., Richard Y., Galanaud P., and Emilie D. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30 (2000) 87-97
57. Rimaniol A.C., Till S.J., Garcia G., Capel F., Godot V., Balabanian K., Durand-Gasselin I., Varga E.M., Simonneau G., Emilie D., Durham S.R., and Humbert M. The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol 112 (2003) 1139-1146
58. Goda S., Imai T., Yoshie O., Yoneda O., Inoue H., Nagano Y., Okazaki T., Imai H., Bloom E.T., Domae N., and Umehara H. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J Immunol 164 (2000) 4313-4320
59. Kerfoot S.M., Lord S.E., Bell R.B., Gill V., Robbins S.M., and Kubes P. Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment. Eur J Immunol 33 (2003) 729-739
60. Ancuta P., Rao R., Moses A., Mehle A., Shaw S.K., Luscinskas F.W., and Gabuzda D. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197 (2003) 1701-1707
61. Dichmann S., Herouy Y., Purlis D., Rheinen H., Gebicke-Harter P., and Norgauer J. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm Res 50 (2001) 529-533
62. Papadopoulos E.J., Fitzhugh D.J., Tkaczyk C., Gilfillan A.M., Sassetti C., Metcalfe D.D., and Hwang S.T. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol 30 (2000) 2355-2361
63. Ancuta P., Moses A., and Gabuzda D. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 209 (2004) 11-20
64. Johnson Z., Schwarz M., Power C.A., Wells T.N., and Proudfoot A.E. Multi-faceted strategies to combat disease by interference with the chemokine system. Trends Immunol 26 (2005) 268-274
65. Nanki T., Urasaki Y., Imai T., Nishimura M., Muramoto K., Kubota T., and Miyasaka N. Inhibition of fractalkine ameliorates murine collagen-induced arthritis. J Immunol 173 (2004) 7010-7016
66. Suzuki F., Nanki T., Imai T., Kikuchi H., Hirohata S., Kohsaka H., and Miyakasa N. Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice. J Immunol 175 (2005) 6987-6996